Summer 2027
Posted on 8/18/2026
Medicare Advantage health insurer for seniors
$18 - $46.54/hr
No H1B Sponsorship
Louisville, KY, USA
In Person
Full-time, on-site attendance is required in Louisville for the 12-week program from May 24 through August 13, 2027.
Bachelor's
See people who can refer or advise you
Humana focuses on health and well-being by offering Medicare Advantage plans (HMO, PPO, and PFFS) mainly for seniors, military personnel, and communities. Its products are health insurance plans funded through a mix of government contracts and member premiums, enrolling members to provide comprehensive coverage with flexible benefits and a broad provider network. Members receive care through a network of providers, with additional services such as free language interpretation to improve accessibility. Humana differentiates itself through its emphasis on inclusivity, accessibility, and tailored benefits, aiming to deliver reliable service and high renewal rates. The goal is to improve health outcomes and overall well-being for members by delivering coverage that meets diverse needs and making care accessible to all.
Company Size
10,001+
Company Stage
IPO
Headquarters
Louisville, Kentucky
Founded
1961
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Unlimited Paid Time Off
Paid Vacation
Paid Parental Leave
Short-term Disability
Long-term Disability
401(k) Retirement Plan
401(k) Company Match
Wellness Program
Nearly 3 million older Americans will lose their Medicare Advantage plans this year, according to Johns Hopkins Bloomberg School of Public Health research. One in 10 Medicare Advantage policyholders face forced disenrollment, with Vermont hit hardest at 92% of policyholders affected. Humana announced its exit from multiple markets for the second consecutive year, impacting 600,000 members. The company reported $1.9 billion profit in the first half of 2026. Insurers cite financial pressures from federal policy changes aimed at reducing overpayments, resulting in lower government reimbursement rates. Combined with rising medical costs, these factors are squeezing profit margins. Shannon Benton of Senior Citizens League said Humana's decision shows Medicare Advantage insurers are "prioritising profit growth over enrollment growth.
Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.
Humana announced plans to exit additional Medicare Advantage plans in 2027, affecting approximately 600,000 members. The US insurer is targeting lower-return plans as part of its strategy to achieve a sustainable 3% pre-tax margin by 2028. Chief financial officer Celeste Mellet said the company expects to retain just over 40% of affected members through other offerings, similar to its 2025 experience. Humana is prioritising higher-performing plans with stronger value-based care penetration. The announcement followed Humana's second-quarter earnings report, which showed adjusted earnings of $7.61 per share on revenue of $40.89 billion. Individual Medicare Advantage membership increased 23% year-over-year to 6.45 million.
GE HealthCare Technologies topped the S&P 500 on Wednesday morning whilst Humana lagged after both reported better-than-expected second-quarter earnings. GEHC shares jumped 11.7% to $71.60, breaking above their recent trading range. Earnings rose 6.6% to $1.13 per share, beating forecasts by 9 cents. Revenue climbed 5.9% to $5.295 billion, slightly exceeding estimates. The company maintained its full-year earnings guidance of $4.80 to $5 per share. Humana shares fell 6.6% to $363.18 despite posting earnings of $7.61 per share, up 21% year-on-year and 35 cents above expectations. Revenue increased 26% to $40.867 billion. However, the company maintained its prior full-year outlook and expects adjusted earnings per share of minus $1.00 in the third quarter. The contrasting market reactions reflected ongoing sector dynamics, with managed-care stocks generally outperforming medical equipment stocks this year.
Humana cut its 2026 earnings outlook on Wednesday after lower Medicare Advantage Star Ratings reduced quality bonuses from the federal government. The health insurer revised its full-year GAAP earnings target to a minimum of $6.52 per share, down from at least $8.36 per share previously. The company's second-quarter profit reached $694 million, or $5.73 per share, versus $545 million a year earlier. Total revenue rose 26% to $40.87 billion. A significant decline in plans rated four stars or higher has weighed on 2026 bonus payments. Medicare Advantage Star Ratings, which run from one to five, are tied to bonus payments from the Centers for Medicare and Medicaid Services. Humana stock fell about 9% in premarket trading Wednesday.